We are live on
!
Find out more
KIC
Kensington Investment Counsel Portfolio holdings
AUM
$208M
1-Year Est. Return
11.99%
This Fund
S&P 500
This Quarter
Est. Return
-12.42%
1 Year Est. Return
+11.99%
3 Year Est. Return
+61.57%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$117M
AUM Growth
-$33.9M
(-22%)
Cap. Flow
-$15.3M
Cap. Flow
% of AUM
-13.02%
Top 10 Holdings %
Top 10 Hldgs %
27.86%
Holding
89
New
2
Increased
6
Reduced
66
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$998K |
| 2 |
Repligen
RGEN
|
+$696K |
| 3 |
Salesforce
CRM
|
+$639K |
| 4 |
Verizon
VZ
|
+$130K |
| 5 |
Illinois Tool Works
ITW
|
+$100K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regions Financial
RF
|
+$3.25M |
| 2 |
KeyCorp
KEY
|
+$3.15M |
| 3 |
Citizens Financial Group
CFG
|
+$2.96M |
| 4 |
Intel
INTC
|
+$2.14M |
| 5 |
Cathay General Bancorp
CATY
|
+$1.37M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.99% |
| 2 | Healthcare | 21.69% |
| 3 | Industrials | 12.21% |
| 4 | Financials | 11.25% |
| 5 | Consumer Staples | 11.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Emerson Electric
EMR
$91.4B
| $1.6M | 1.37% |
20,164
-336
| -2% | -$29.6K |
|
27
Nasdaq
NDAQ
$53.5B
| $1.59M | 1.35% |
31,185
-684
| -2% | -$36.2K |
|
28
Copart
CPRT
$26.8B
| $1.58M | 1.35% |
58,140
-1,268
| -2% | -$36.1K |
|
29
Ametek
AME
$59.3B
| $1.55M | 1.32% |
14,126
-317
| -2% | -$38.5K |
|
30
US Bancorp
USB
$101B
| $1.55M | 1.32% |
33,613
-548
| -2% | -$27.4K |
|
|
31
Repligen
RGEN
$9.35B
| $1.51M | 1.28% |
9,274
+4,402
| +90% | +$696K |
|
32
Clorox
CLX
$12.8B
| $1.5M | 1.28% |
10,649
-251
| -2% | -$35.9K |
|
33
Starbucks
SBUX
$124B
| $1.5M | 1.28% |
19,643
-652
| -3% | -$50.1K |
|
34
Procter & Gamble
PG
$335B
| $1.49M | 1.27% |
10,347
-164
| -2% | -$24.6K |
|
35
Invesco QQQ Trust
QQQ
$481B
| $1.48M | 1.26% |
5,264
| – | – |
|
36
Alphabet (Google) Class A
GOOGL
$4.2T
| $1.46M | 1.24% |
13,380
-300
| -2% | -$35.3K |
|
37
UnitedHealth
UNH
$364B
| $1.44M | 1.23% |
2,799
-65
| -2% | -$32.6K |
|
38
Omnicell
OMCL
$1.69B
| $1.42M | 1.21% |
12,499
-206
| -2% | -$23.6K |
|
39
JPMorgan Chase
JPM
$971B
| $1.39M | 1.18% |
12,307
-216
| -2% | -$26.8K |
|
40
Danaher
DHR
$145B
| $1.36M | 1.16% |
6,044
-115
| -2% | -$26.5K |
|
41
ResMed
RMD
$32.8B
| $1.27M | 1.08% |
6,045
-142
| -2% | -$30.2K |
|
42
LKQ Corp
LKQ
$6.25B
| $1.27M | 1.08% |
25,780
-663
| -3% | -$32.7K |
|
43
Bristol-Myers Squibb
BMY
$130B
| $1.2M | 1.03% |
15,626
-272
| -2% | -$20.7K |
|
44
Amazon
AMZN
$2.88T
| $1.15M | 0.98% |
10,840
| – | – |
|
45
Novartis
NVS
$290B
| $1.15M | 0.98% |
13,585
-235
| -2% | -$20.6K |
|
46
Littelfuse
LFUS
$11.7B
| $1.12M | 0.96% |
4,425
-104
| -2% | -$26.1K |
|
|
47
Illinois Tool Works
ITW
$83.3B
| $1.11M | 0.95% |
6,111
+501
| +9% | +$100K |
|
48
Five Below
FIVE
$13.2B
| $1.11M | 0.94% |
9,759
-240
| -2% | -$34.5K |
|
49
Sherwin-Williams
SHW
$87.4B
| $1.1M | 0.94% |
4,934
-158
| -3% | -$40.5K |
|
50
CrowdStrike
CRWD
$226B
| $1.1M | 0.94% |
26,144
-628
| -2% | -$28.4K |
|
Similar funds
HCA
FHWM
SNBOSD
MIP
SG
MPCG
EPG
CC
Kensington Investment Counsel's Q2 2022 Portfolio in Review
As of Q2 2022, Kensington Investment Counsel held 89 positions worth $117M, down 22% from $151M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Kensington Investment Counsel withdrew a net $15.3M in Q2 2022, closing 9 positions and reducing 66 holdings. Its most notable exit was Regions Financial, an estimated $3.25M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Kensington Investment Counsel opened a new position in Thermo Fisher Scientific worth $985K.
- Kensington Investment Counsel's largest Q2 2022 buy was Thermo Fisher Scientific: 1,813 shares worth $985K.
- Kensington Investment Counsel added most to Repligen in Q2 2022, an estimated $696K increase.
- Kensington Investment Counsel's biggest Q2 2022 reduction was Qualcomm, cutting an estimated $118K.
- Kensington Investment Counsel fully exited Regions Financial in Q2 2022, selling an estimated $3.25M.
- Kensington Investment Counsel's ten largest holdings make up 28% of its $117M portfolio in Q2 2022.
- Kensington Investment Counsel opened 2 new positions and closed 9 in Q2 2022.
- Kensington Investment Counsel's portfolio value fell 22% quarter-over-quarter to $117M.
Based on Kensington Investment Counsel's 13F filing for Q2 2022, filed 15 Jul 2022.